CLINICAL_TRIALS
trial_result
· 2012-07-04
Clinical Trial Update: Telmisartan 80mg Non-responder Trial [Phase 3]
Summary
A Phase 3 trial evaluating telmisartan 80 mg in hypertension non-responders has completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04